GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Viemed Healthcare Inc (NAS:VMD) » Definitions » Return-on-Tangible-Asset

Viemed Healthcare (Viemed Healthcare) Return-on-Tangible-Asset : 5.15% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Viemed Healthcare Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Viemed Healthcare's annualized Net Income for the quarter that ended in Mar. 2024 was $6.4 Mil. Viemed Healthcare's average total tangible assets for the quarter that ended in Mar. 2024 was $124.6 Mil. Therefore, Viemed Healthcare's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was 5.15%.

The historical rank and industry rank for Viemed Healthcare's Return-on-Tangible-Asset or its related term are showing as below:

VMD' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 4.98   Med: 10.5   Max: 32.31
Current: 8.45

During the past 8 years, Viemed Healthcare's highest Return-on-Tangible-Asset was 32.31%. The lowest was 4.98%. And the median was 10.50%.

VMD's Return-on-Tangible-Asset is ranked better than
78.94% of 864 companies
in the Medical Devices & Instruments industry
Industry Median: -2.715 vs VMD: 8.45

Viemed Healthcare Return-on-Tangible-Asset Historical Data

The historical data trend for Viemed Healthcare's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viemed Healthcare Return-on-Tangible-Asset Chart

Viemed Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial 12.51 32.31 7.92 5.30 8.48

Viemed Healthcare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.02 7.66 9.83 11.42 5.15

Competitive Comparison of Viemed Healthcare's Return-on-Tangible-Asset

For the Medical Devices subindustry, Viemed Healthcare's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viemed Healthcare's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Viemed Healthcare's Return-on-Tangible-Asset falls into.



Viemed Healthcare Return-on-Tangible-Asset Calculation

Viemed Healthcare's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=10.243/( (117.043+124.563)/ 2 )
=10.243/120.803
=8.48 %

Viemed Healthcare's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=6.412/( (124.563+124.576)/ 2 )
=6.412/124.5695
=5.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


Viemed Healthcare  (NAS:VMD) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Viemed Healthcare Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Viemed Healthcare's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Viemed Healthcare (Viemed Healthcare) Business Description

Traded in Other Exchanges
Address
625 E. Kaliste Saloom Road, Lafayette, LA, USA, 70508
Viemed Healthcare Inc is a provider of equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services.
Executives
Jeremy Trahan officer: Chief Legal Officer 625 E. KALISTE SALOOM RD., LAFAYETTE LA 70508
Timothy Smokoff director 625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Nitin Kaushal director 625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Randy E. Dobbs director C/O VIEMED HEALTHCARE, INC, 625 E. KALISTE SALOOM RD, LAFAYETTE LA 70508
Bruce D Greenstein director 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508
William Todd Zehnder director, officer: Chief Operating Officer 400 E. KALISTE SALOOM ROAD, SUITE 6000, LAFAYETTE LA 70508
Casey Hoyt director, officer: Chief Executive Officer 625 E. KALISTE SALOOM RD., LAFAYETTE LA 70508
Michael Moore officer: President 625 E. KALISTE SALOOM RD., LAFAYETTE LA 70508
Trae Fitzgerald officer: Chief Financial Officer 625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
William Frazier director, officer: Chief Medical Officer 625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Jerome Cambre officer: Vice President of Sales 625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Sabrina Heltz director 625 E. KALISTE SALOOM ROAD, LAFAYETTE LA 70508
Ewell Patrick Eagan officer: General Counsel 625 E. KALISTE SALOOM ROAD, LAFAYETTE LA 70508